Samidin
CAS: 477-33-8
Ref. 3D-AAA47733
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado |
Informação sobre produto
Nome:
Samidin
Sinónimos:
- 2-Butenoic acid, 3-methyl-, 10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b′]dipyran-9-yl ester, (9R-cis)-
- 2H,8H-Benzo[1,2-b:3,4-b′]dipyran, 2-butenoic acid deriv.
- 2-Butenoic acid, 3-methyl-, (9R,10R)-10-(acetyloxy)-9,10-dihydro-8,8-dimethyl-2-oxo-2H,8H-benzo[1,2-b:3,4-b′]dipyran-9-yl ester
- Crotonic acid, 3-methyl-, 9-ester with 9,10-dihydro-9,10-dihydroxy-8,8-dimethyl-2H,8H-benzo[1,2-b:3,4-b′]dipyran-2-one acetate
Descrição:
Samidin is a soybean trypsin inhibitor that has been shown to have an inhibitory effect on heart tissue. It is a potent inhibitor of the enzyme, having an IC50 of 3.2 μM for soybean trypsin and a K1/2 value of 2.6 μM. Samidin has been shown to be effective in controlling diabetes mellitus by reducing the activity of fatty acid synthase, which is responsible for the synthesis of fatty acids from acetyl-CoA and malonyl-CoA. Samidin also has anti-inflammatory properties and can be used as a treatment for inflammatory diseases such as cancer or arthritis. Furthermore, it has been shown to reduce the growth of cancer cells through its inhibition of DNA synthesis and protein synthesis in mammalian cells.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
386.4 g/mol
Fórmula:
C21H22O7
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
